Rencová J, Volf V, Jones M M, Singh P K, Filgas R
National Institute of Public Health, Centre of Radiation Hygiene, Praha, Czech Republic.
Int J Radiat Biol. 1995 Feb;67(2):229-34. doi: 10.1080/09553009514550281.
The time dependence of organ distribution and excretion of intravenously (iv) injected 210Po was investigated after the single or repeated administration of N,N'-diethylamine-N-carbodithioate (diethyldithiocarbamate, DDTC) and three bis-dithiocarbamates: N,N'-dimethylethylenediamine-N,N'-biscarbodithioate (MeTTC), N,N'-diethylethylenediamine-N,N'-biscarbodithioate (EtTTC), and N,N'-di)20hydroxyethyl)ethylenediamine-N,N'-biscarbodithioate++ + (HOEtTTC). The biokinetics of iv injected 210Po was used as a model for the behaviour of 210Po absorbed into the blood from any other site of entry into the body. The most effective chelating agent was HOEtTTC, which was not only effective when injected subcutaneously (sc) immediately after 210Po, but also 1 h later. Toxic effects of DDTC were observed in a metabolic study when the effect of HOEtTTC was compared with that of DDTC. DDTC caused accumulation of 210Po in brain and transiently in liver. When HOEtTTC was administered, the faecal excretion of 210Po was increased from the very beginning. MeTTC, EtTTC and N-(2,3-dimercaptopropyl)phtalamidic acid (DMPA) were ineffective when the treatment started 1 h after iv injection of 210Po.
在单次或重复给予N,N'-二乙胺-N-碳二硫代酸盐(二乙基二硫代氨基甲酸盐,DDTC)以及三种双二硫代氨基甲酸盐:N,N'-二甲基乙二胺-N,N'-双碳二硫代酸盐(MeTTC)、N,N'-二乙基乙二胺-N,N'-双碳二硫代酸盐(EtTTC)和N,N'-二(2-羟乙基)乙二胺-N,N'-双碳二硫代酸盐(HOEtTTC)之后,研究了静脉注射210Po后器官分布和排泄的时间依赖性。静脉注射210Po的生物动力学被用作从身体任何其他进入部位吸收到血液中的210Po行为的模型。最有效的螯合剂是HOEtTTC,它不仅在210Po注射后立即皮下注射有效,而且在1小时后也有效。在一项代谢研究中,当将HOEtTTC的效果与DDTC的效果进行比较时,观察到了DDTC的毒性作用。DDTC导致210Po在脑中蓄积,并在肝脏中短暂蓄积。当给予HOEtTTC时,210Po从一开始粪便排泄就增加。当在静脉注射210Po 1小时后开始治疗时,MeTTC、EtTTC和N-(2,3-二巯基丙基)邻苯二甲酰胺酸(DMPA)无效。